Citation: A. Morinville et al., FROM VANADIS TO ATROPOS - VANADIUM COMPOUNDS AS PHARMACOLOGICAL TOOLSIN CELL-DEATH SIGNALING, Trends in pharmacological sciences, 19(11), 1998, pp. 452-460
Citation: C. Allen et al., POLYCAPROLACTONE-B-POLY(ETHYLENE OXIDE) BLOCK-COPOLYMER MICELLES AS ANOVEL DRUG-DELIVERY VEHICLE FOR NEUROTROPHIC AGENTS FK506 AND L-685,818, Bioconjugate chemistry, 9(5), 1998, pp. 564-572
Authors:
KRIEGLSTEIN K
REUSS B
MAYSINGER D
UNSICKER K
Citation: K. Krieglstein et al., TRANSFORMING-GROWTH-FACTOR-BETA MEDIATES THE NEUROTROPHIC EFFECT OF FIBROBLAST GROWTH FACTOR-2 ON MIDBRAIN DOPAMINERGIC-NEURONS, European journal of neuroscience, 10(8), 1998, pp. 2746-2750
Citation: J. Mrsic et al., HYPOGLYCEMIC EFFECTS AND MODULATION OF NA,K-ATPASE ACTIVITY IN HIPPOCAMPUS AND CORTEX OF DIABETIC RATS WITH PEROXOVANADIUM COMPOUND, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1939-1939
Authors:
HERRERA DG
MAYSINGER D
ALMAZAN G
FUNNEL R
CUELLO AC
Citation: Dg. Herrera et al., ANALYSIS OF C-FOS AND GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP) EXPRESSION FOLLOWING TOPICAL APPLICATION OF POTASSIUM-CHLORIDE (KCI) TO THE BRAIN SURFACE, Brain research, 784(1-2), 1998, pp. 71-81
Citation: S. Fedoroff et al., ROLE OF COLONY-STIMULATING FACTOR-I IN BRAIN-DAMAGE CAUSED BY ISCHEMIA, Neuroscience and biobehavioral reviews, 21(2), 1997, pp. 187-191
Authors:
PARASKEVAS S
DUGUID WP
MAYSINGER D
FELDMAN L
AGAPITOS D
ROSENBERG L
Citation: S. Paraskevas et al., APOPTOSIS OCCURS IN FRESHLY ISOLATED HUMAN ISLETS UNDER STANDARD CULTURE CONDITIONS, Transplantation proceedings, 29(1-2), 1997, pp. 750-752
Citation: K. Krieglstein et al., THE SURVIVAL RESPONSE OF MESENCEPHALIC DOPAMINERGIC-NEURONS TO THE NEUROTROPHINS BDNF AND NT-4 REQUIRES PRIMING WITH SERUM - COMPARISON WITH MEMBERS OF THE TGF-BETA SUPERFAMILY AND CHARACTERIZATION OF THE SERUM-FREE CULTURE SYSTEM, Journal of neural transmission. Supplementum, (47), 1996, pp. 247-258
Citation: D. Maysinger et al., THE HEMATOPOIETIC CYTOKINE COLONY-STIMULATING FACTOR-1 IS ALSO A GROWTH-FACTOR IN THE CNS .2. MICROENCAPSULATED CSF-I AND LM-10 CELLS AS DELIVERY SYSTEMS, Experimental neurology, 141(1), 1996, pp. 47-56
Authors:
MAYSINGER D
KRIEGLSTEIN K
FILIPOVICGRCIC J
SENDTNER M
UNSICKER K
RICHARDSON P
Citation: D. Maysinger et al., MICROENCAPSULATED CILIARY NEUROTROPHIC FACTOR - PHYSICAL-PROPERTIES AND BIOLOGICAL-ACTIVITIES, Experimental neurology, 138(2), 1996, pp. 177-188
Citation: O. Berezovskaya et al., COLONY-STIMULATING FACTOR-I POTENTIATES NEURONAL SURVIVAL IN CEREBRAL-CORTEX ISCHEMIC LESION, Acta Neuropathologica, 92(5), 1996, pp. 479-486
Citation: O. Berezovskaya et al., THE HEMATOPOIETIC CYTOKINE, COLONY-STIMULATING FACTOR-1, IS ALSO A GROWTH-FACTOR IN THE CNS - CONGENITAL ABSENCE OF CSF-1 IN MICE RESULTS IN ABNORMAL MICROGLIAL RESPONSE AND INCREASED NEURON VULNERABILITY TO INJURY, International journal of developmental neuroscience, 13(3-4), 1995, pp. 285-299
Authors:
FILIPOVICGRCIC J
MAYSINGER D
ZORC B
JALSENJAK I
Citation: J. Filipovicgrcic et al., MACROMOLECULAR PRODRUGS .4. ALGINATE-CHITOSAN MICROSPHERES OF PHEA-L-DOPA ADDUCT, International journal of pharmaceutics, 116(1), 1995, pp. 39-44
Authors:
RATNAKUMARI L
QURESHI IA
MAYSINGER D
BUTTERWORTH RF
Citation: L. Ratnakumari et al., DEVELOPMENTAL DEFICIENCY OF THE CHOLINERGIC SYSTEM IN CONGENITALLY HYPERAMMONEMIC SPF MICE - EFFECT OF ACETYL-L-CARNITINE, The Journal of pharmacology and experimental therapeutics, 274(1), 1995, pp. 437-443
Citation: S. Luterotti et D. Maysinger, CHEMILUMINOMETRIC DETERMINATION OF CHOLINE-RELATED SUBSTANCES IN PHARMACEUTICAL PREPARATIONS BY DOT-BLOT, Journal of pharmaceutical and biomedical analysis, 12(9), 1994, pp. 1083-1090
Authors:
MAYSINGER D
PICCARDO P
LIBERINI P
JALSENJAK I
CUELLO AC
Citation: D. Maysinger et al., ENCAPSULATED GENETICALLY-ENGINEERED FIBROBLASTS - RELEASE OF NERVE GROWTH-FACTOR AND EFFECTS IN-VIVO ON RECOVERY OF CHOLINERGIC MARKERS AFTER DEVASCULARIZING CORTICAL-LESIONS, Neurochemistry international, 24(5), 1994, pp. 495-503
Authors:
LIBERINI P
PIORO EP
MAYSINGER D
CUELLO AC
Citation: P. Liberini et al., NEOCORTICAL INFARCTION IN SUBHUMAN PRIMATES LEADS TO RESTRICTED MORPHOLOGICAL DAMAGE OF THE CHOLINERGIC NEURONS IN THE NUCLEUS BASALIS OF MEYNERT, Brain research, 648(1), 1994, pp. 1-8
Authors:
ZORC B
LJUBIC M
ANTOLIC S
FILIPOVICGRCIC J
MAYSINGER D
ALEBICKOLBAH T
JALSENJAK I
Citation: B. Zorc et al., MACROMOLECULAR PRODRUGS .2. ESTERS OF L-DOPA AND ALPHA-METHYLDOPA, International journal of pharmaceutics, 99(2-3), 1993, pp. 135-143
Authors:
FIGUEIREDO BC
PICCARDO P
MAYSINGER D
CLARKE PBS
CUELLO AC
Citation: Bc. Figueiredo et al., EFFECTS OF ACIDIC FIBROBLAST GROWTH-FACTOR ON CHOLINERGIC NEURONS OF NUCLEUS BASALIS MAGNOCELLULARIS AND IN A SPATIAL MEMORY TASK FOLLOWINGCORTICAL DEVASCULARIZATION, Neuroscience, 56(4), 1993, pp. 955-963